Market Overview

UPDATE: Stifel Nicolaus Downgrades VCA Antech to Sell on Long-Term Lab Headwinds

Related WOOF
Will Trupanion's New Pet Insurance IPO Succeed?
Top 4 NASDAQ Stocks In The Personal Services Industry With The Highest ROI

Stifel Nicolaus downgraded VCA Antech (NASDAQ: WOOF) from Hold to Sell.

Stifel Nicolaus noted, "Our work uncovers what we believe are long-term systemic issues at the high margin lab business (estimated 35%-40% of total company operating profit) which may result in continued market share losses. With VCA trading at the upper end of its three-year NTM P/E range, we believe the stock's performance will lag going forward. … While some of VCA's long-term lab challenges have been well vetted (no lab/point-of-care ("POC") bundle, lack of specialty tests, etc.), our work uncovers a potentially more troubling headwind. We believe VCA's animal hospital presence is alienating other veterinary practices from using VCA's high margin reference lab. This issue is likely to continue (if not worsen) as VCA continues to build out its hospital network."

VCA Antech closed at $21.95 on Friday.

Posted-In: Stifel NicolausAnalyst Color Downgrades Intraday Update Analyst Ratings

 

Most Popular

Related Articles (WOOF)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free